Jpmorgan Chase & CO Boston Scientific Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 26,039,392 shares of BSX stock, worth $2.36 Billion. This represents 0.18% of its overall portfolio holdings.

Number of Shares

26,039,392

Previous 26,563,675 1.97%

Holding current value

$2.36 Billion

Previous $2.05 Billion 6.67%

% of portfolio

0.18%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$72.96 - $84.0 $38.3 Million - $44 Million	-524,283 Reduced 1.97%	26,039,392 $2.18 Billion
Q3 2024 Nov 08, 2024	SELL	$72.96 - $84.0 $38.3 Million - $44 Million	-524,283 Reduced 1.97%	26,039,392 $2.18 Billion
Q2 2024 Dec 26, 2024	BUY	$67.33 - $77.71 $35.3 Million - $40.7 Million	524,283 Added 2.01%	26,563,675 $2.05 Billion
Q2 2024 Aug 12, 2024	SELL	$67.33 - $77.71 $331 Million - $382 Million	-4,915,959 Reduced 15.62%	26,563,675 $2.05 Billion
Q1 2024 Dec 26, 2024	BUY	$57.6 - $68.62 $313 Million - $373 Million	5,440,242 Added 20.89%	31,479,634 $2.16 Billion
Q1 2024 May 10, 2024	BUY	$57.6 - $68.62 $164 Million - $195 Million	2,845,922 Added 9.94%	31,479,634 $2.16 Billion
Q4 2023 Dec 26, 2024	BUY	$48.64 - $57.81 $126 Million - $150 Million	2,594,320 Added 9.96%	28,633,712 $1.66 Billion
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $220 Million - $262 Million	4,529,740 Added 18.79%	28,633,712 $1.66 Billion
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $47.2 Million - $51.4 Million	940,531 Added 4.06%	24,103,972 $1.27 Billion
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $523 Million - $575 Million	-10,514,440 Reduced 31.22%	23,163,441 $1.25 Billion
Q1 2023 May 18, 2023	BUY	$45.09 - $50.03 $30.4 Million - $33.7 Million	674,105 Added 2.04%	33,677,881 $1.68 Billion
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $650 Million - $722 Million	-14,421,770 Reduced 30.41%	33,003,776 $1.65 Billion
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $127 Million - $152 Million	-3,214,061 Reduced 6.35%	47,425,546 $2.19 Billion
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $31.9 Million - $95.4 Million	-870,168 Reduced 1.69%	50,639,607 $1.96 Billion
Q2 2022 Aug 11, 2022	BUY	$35.24 - $47.1 $132 Million - $176 Million	3,738,113 Added 7.82%	51,509,775 $1.92 Billion
Q1 2022 May 11, 2022	BUY	$40.9 - $45.1 $39.1 Million - $43.1 Million	956,611 Added 2.04%	47,771,662 $2.12 Billion
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $359 Million - $423 Million	9,427,386 Added 25.22%	46,815,051 $1.99 Billion
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $1.54 Billion - $1.72 Billion	37,387,665 New	37,387,665 $1.62 Billion

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Boston Scientific Corp Transaction History